Skip to main content

Table 2 Average of 2 (-ΔΔCT) Values in Apoptotic Genes Depicted Fold Change

From: Effect of glucose mediated oxidative stress on apoptotic gene expression in gingival mesenchymal stem cells

Target Name

18S (2^-∆∆CT)

ACTB (2^-∆∆CT)

GAPDH (2^-∆∆CT)

Average of (2^-∆∆CT)

Target Name

18S (2^-∆∆CT)

ACTB (2^-∆∆CT)

GAPDH (2^-∆∆CT)

Average of (2^-∆∆CT)

APAF1

1.28

1.72

0.81

1.27

BAX

1.43

1.92

0.90

1.42

BAD

0.65

0.87

0.41

0.64

BBC3

0.92

1.24

0.58

0.91

BAK1

0.92

1.24

0.58

0.92

BCAP31

0.97

1.31

0.62

0.97

BCL10

1.93

2.59

1.22

1.91

DEDD2

1.24

1.66

0.78

1.23

BCL2A1

4.80

6.46

3.04

4.76

DEDD

2.50

3.36

1.58

2.48

BCL2

0.09

0.12

0.06

0.09

DIABLO

1.39

1.87

0.88

1.38

BCL2L10

0.95

1.28

0.60

0.95

ESRRBL1

1.13

1.52

0.72

1.12

BCL2L11

3.49

4.70

2.21

3.46

FADD

0.83

1.12

0.52

0.82

BCL2L13

1.53

2.06

0.97

1.52

FAS

1.19

1.60

0.75

1.18

BCL2L14

29.80

40.13

18.86

29.59

FASLG

18.53

24.95

11.73

18.40

BCL2L1

1.36

1.83

0.86

1.35

HIP1

1.59

2.14

1.01

1.58

BCL2L2

1.32

1.78

0.83

1.31

HRK

0.59

0.80

0.37

0.59

BCL3

2.40

3.24

1.52

2.39

HTRA2

2.04

2.75

1.29

2.02

BID

0.96

1.29

0.61

0.95

ICEBERG

0.04

0.05

0.02

0.04

BIK

0.95

1.28

0.60

0.95

IKBKB

1.43

1.93

0.91

1.42

BIRC1

0.79

1.06

0.50

0.78

IKBKE

2.70

3.63

1.71

2.68

BIRC2

2.05

2.76

1.30

2.04

IKBKG

1.21

1.63

0.77

1.20

BIRC3

0.80

1.08

0.51

0.79

LRDD

1.51

2.04

0.96

1.50

BIRC4

1.82

2.46

1.15

1.81

LTA

4.23

5.69

2.67

4.20

BIRC5

0.36

0.48

0.23

0.35

LTB

0.58

0.78

0.37

0.58

BIRC6

1.98

2.67

1.25

1.97

MCL1

1.43

1.93

0.91

1.42

BIRC7

0.95

1.28

0.60

0.95

NALP1

2.18

2.93

1.38

2.16

BIRC8

0.67

0.90

0.42

0.66

NFKB1

1.94

2.61

1.23

1.92

BNIP3

1.66

2.24

1.05

1.65

NFKB2

1.69

2.27

1.07

1.68

BNIP3L

2.53

3.41

1.60

2.51

NFKBIA

4.68

6.30

2.96

4.64

BOK

0.89

1.20

0.56

0.89

NFKBIB

1.56

2.09

0.98

1.54

CARD15

1.68

2.27

1.07

1.67

NFKBIE

1.41

1.90

0.89

1.40

CARD4

0.90

1.21

0.57

0.89

NFKBIZ

0.72

0.97

0.45

0.71

CARD6

3.48

4.69

2.21

3.46

PEA15

1.53

2.05

0.97

1.52

CARD9

0.24

0.33

0.15

0.24

PMAIP1

5.43

7.31

3.44

5.39

CASP10

0.72

0.97

0.46

0.71

PYCARD

1.87

2.51

1.18

1.85

CASP14

0.95

1.28

0.60

0.95

RELA

1.91

2.58

1.21

1.90

CASP1

1.36

1.83

0.86

1.35

RELB

0.91

1.22

0.57

0.90

CASP2

1.56

2.10

0.99

1.55

REL

2.24

3.02

1.42

2.23

CASP3

1.91

2.58

1.21

1.90

RIPK1

2.81

3.78

1.78

2.79

CASP4

1.59

2.14

1.01

1.58

RIPK2

1.99

2.68

1.26

1.98

CASP5

1.37

1.85

0.87

1.36

TA-NFKBH

1.37

1.85

0.87

1.36

CASP6

1.70

2.29

1.08

1.69

TBK1

2.97

3.99

1.88

2.95

CASP7

1.74

2.34

1.10

1.73

TNF

99.15

133.52

62.75

98.47

CASP8AP2

2.06

2.77

1.30

2.04

TNFRSF10A

1.84

2.48

1.17

1.83

CASP8

2.11

2.84

1.34

2.10

TNFRSF10B

1.15

1.55

0.73

1.15

CASP9

1.00

1.34

0.63

0.99

TNFRSF1A

1.79

2.41

1.13

1.78

CFLAR

1.79

2.40

1.13

1.77

TNFRSF1B

1.87

2.52

1.19

1.86

CHUK

1.60

2.16

1.01

1.59

TNFRSF21

0.56

0.75

0.35

0.55

CRADD

1.15

1.55

0.73

1.15

TNFRSF25

0.85

1.15

0.54

0.85

DAPK1

3.29

4.43

2.08

3.26

TNFSF10

46.77

62.98

29.60

46.45

Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us